A61K 38/1729
Cationic antimicrobial peptides
Official title: {Cationic antimicrobial peptides, e.g. defensins}
A61K38/1729 (Cationic antimicrobial peptides) appears on 95 US grants and 226 published applications in this corpus.
Search patents in A61K- Granted patents
- 95
- Published applications
- 226
- Assignees
- 127
- Inventors
- 419
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 3 |
| 2004 | 1 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 5 |
| 2007 | 0 | 3 |
| 2008 | 1 | 4 |
| 2009 | 2 | 6 |
| 2010 | 0 | 12 |
| 2011 | 1 | 5 |
| 2012 | 5 | 10 |
| 2013 | 3 | 12 |
| 2014 | 5 | 11 |
| 2015 | 9 | 8 |
| 2016 | 6 | 11 |
| 2017 | 5 | 12 |
| 2018 | 5 | 10 |
| 2019 | 8 | 13 |
| 2020 | 3 | 12 |
| 2021 | 5 | 14 |
| 2022 | 4 | 16 |
| 2023 | 5 | 14 |
| 2024 | 11 | 21 |
| 2025 | 8 | 12 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Application of Caerin 1.1/1.9 combined with anti-CD47 antibody in preparing drug for treating melanoma11 Aug 2026US 12,702,702 B2Wnl Biomed Tech Pty. Ltd.
- Therapeutic nanoparticles by coacervate complexation and their use for treating bacteria10 Mar 2026US 12,569,534 B2Academia Sinica
- Antibody fragment based antifungal conjugate selectively targeting candida10 Mar 2026US 12,570,729 B2Abgenics Lifesciences Private Limited
- Oral composition and methods6 Jan 2026US 12,514,903 B2Wenzhou Qingcheng Healthcare Tech Ltd.
- Use of peptide for inhibiting functions and expressions of multiple disease biomarkers2 Dec 2025US 12,486,303 B2Nibec Co., Ltd.
- Compositions and Methods for Treatment of Protease Mediated Disease24 Sep 2026US 2026/0284144 A1The Regents of the University of California
- Antimicrobial peptide delivery system and manufacturing method based on gold nanoparticle-aptamer conjugate27 Aug 2026US 2026/0248950 A1Nes Biotechnology Co., Ltd.
- Composition of antibacterial protein for treating bovine mastitis27 Aug 2026US 2026/0250339 A1
- SS-defensin-2 peptide for inhibiting cell growth of colon cancer16 Apr 2026US 2026/0102466 A1King Abdulaziz University
- Diels-alder conjugation methods26 Feb 2026US 2026/0053938 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix365US 6,309,669 B1The United States of America as represented by the Secretary of the Army · 2001
- Engineered nucleic acids and methods of use thereof184US 9,464,124 B2Moderna Therapeutics, Inc. · 2016
- Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis165US 6,716,813 B2House Ear Institute · 2004
- Enhancement of antimicrobial peptide activity by metal ions108US 6,042,848 ABoard of Trustees of Southern Illinois University · 2000
- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix26US 6,844,010 B1The United States of America as represented by the Secretary of the Army · 2005